UNC Health Medication Formulary
QR Code Add Formweb to your mobile device
Click here to submit safety event reports via SAFE
UNC Health Medication Formulary

<< Back to News

System Formulary Addition
Buprenorphine Buccal Film

Situation

The formulary review of buprenorphine buccal film was approved at the September 2020 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was requested for formulary addition: buprenorphine buccal film (Belbuca)

Assessment/Recommendation

Go-Live: Tuesday, December 15, 2020

System P&T voted to include the following products on the UNC Health Medication Formulary:

  • Buprenorphine buccal film 75 mcg, 150 mcg, 300 mcg

Use of buprenorphine buccal film is restricted to patients continuing home therapy.

Note: Stock of these formulary products may vary at individual entities






This site is intended for the staff of UNC Health.
While others may view accessible pages, UNC Health makes no warranty, express or implied,
as to the use of this information outside of UNC Health.